Surgical Innovations Share Discussion Threads

[justiceforthemany] 16/5/2024 22:17

2.5M bought at 0.47p today
Growing economy, no strikes for a while, hopefully expansion abroad and new sales, lower energy costs, inflation down to 2% April.
Why is the share price static?
Board need to buy stock. Must do so.

[justiceforthemany] 03/5/2024 15:23

More big buys but share price static.

[john148] 02/5/2024 11:05

Nice to see S/P currently up 20% but will it last ?

[justiceforthemany] 29/4/2024 16:41

At some point that NHS backlog has to reduce.
Shift the inventory.
Historical average here is 1-2p.

[cashflo] 25/4/2024 20:55

still rubbish price tho isn't it

[justiceforthemany] 23/4/2024 11:39

Healthinvest buying.
Now holding 7%.

[tubigrip] 22/4/2024 16:57

Rns text - 'This change from above 5% to less than 5% is due to the sale of 3,250,000 shares by Ruffer LLP on 17 April 2024'

[justiceforthemany] 19/4/2024 17:58

Ruffer look to be building a stake here. See RNS.

[john148] 18/4/2024 20:54

Good to see some of the old Board members stepping down. Let's home the new Board members can add something extra to the company.

[mandate] 18/4/2024 15:10

@justiceforthemany thanks

[justiceforthemany] 18/4/2024 14:22

I expect to see net cash around £1M by year end and a positive operating profit.
Group revenue +8% year on year should equal an extra £1M.
Costs hopefully stable to down year on year.
Energy costs down, inflation down.
The company stated they will try to grow revenue substantially via Japan, India and South America (new). Time will tell.

(APH = Alliance Pharma)

[mandate] 18/4/2024 14:14

@Blackhorse23 Who or what is APH?

[blackhorse23] 18/4/2024 11:52

Profit moved to APH

[justiceforthemany] 18/4/2024 11:04

Significant growth opportunities in India and Japan.
Revenue to double within 5 years.
Historically this share has averaged 2p.

[justiceforthemany] 18/4/2024 09:45

The outlook is positive. Revenue is up year on year.
Costs and wages down significantly.
EBITDA is +ve in 2024.
New contracts signed worth 3x the current market cap; revenue is also 3x the whole market cap.
New products released.
Do you really think the whole company is worth £3.9M?
A rich individual could buy it today.

[1choip] 18/4/2024 09:24

Ebitda is under 3% and where were the profits gone? How to finance capex?

[glavey] 18/4/2024 08:51

"Based on what?"

Cash.

[justiceforthemany] 18/4/2024 08:25

Today was the best time to announce one.

[justiceforthemany] 18/4/2024 08:24

Based on what?

[jmf69] 18/4/2024 07:32

I have a feeling they'll need to raise funds soon.

[justiceforthemany] 18/4/2024 07:02

Sell off was unwarranted.
£0.5M reduction in costs/wages this year.
New contracts signed.

[justiceforthemany] 17/4/2024 18:52

PIs could easily buy the whole company down here.

[justiceforthemany] 16/4/2024 21:40

Let's face it at 0.4p and a £4M market cap the market is saying this company is pretty much bust.

[barrenwuffet2] 13/4/2024 16:44

Let us imagine for a moment you are correct and CMR perform 36,000 cases in the coming year. How much do CMR charge for a set of SUN products? Say £50? So SUN would sell them to CMR at around £25.00 - maybe more, maybe less but this order of magnitude.
36,000 x £24 is £900,000.

Is under £1m growth from what you say is a key driver going to change the world for SUN?